Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print Apr 26, 2005
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2003.035485v1
95/5/900    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wise, M. E.
Right arrow Articles by Sorvillo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wise, M. E.
Right arrow Articles by Sorvillo, F.
Related Collections
Right arrow Immunization/Vaccines
Right arrow Hepatitis
Right arrow Mortality
May 2005, Vol 95, No. 5 | American Journal of Public Health 900-905
© 2005 American Public Health Association
DOI: 10.2105/AJPH.2003.035485

RESEARCH AND PRACTICE

Hepatitis A–Related Mortality in California, 1989–2000: Analysis of Multiple Cause–Coded Death Data

Matthew E. Wise, MPH and Frank Sorvillo, MPH, PhD

Matthew E. Wise and Frank Sorvillo are with the Department of Epidemiology, UCLA School of Public Health, Los Angeles, Calif.

Correspondence: Requests for reprints should be sent to Matthew E. Wise, MPH, UCLA Dept of Epidemiology, Center for the Health Sciences, Rm 71–254, Box 951772, Los Angeles, CA 90095–1772 (e-mail: mawise{at}ladhs.org).

Objectives. We estimated the hepatitis A (HA) mortality rate in California, assessed demographic differences in HA-related mortality, and examined comorbidities listed on death certificates in order to provide information for health policy and planning related to HA vaccination.

Methods. We identified HA-related deaths in California from 1989 to 2000 with multiple-cause-of-death files and calculated mortality rates and rate ratios.

Results. We identified 402 HA-related deaths between 1989 and 2000; the annual age-adjusted HA-related mortality rate was 1.20 deaths per 1 million persons. Older individuals, men, Latinos, and American Indians/Alaska Natives had elevated mortality rates. Liver conditions and non-A viral hepatitis infections were more common among HA-related deaths than among all other deaths.

Conclusions. Current immunization practices should be reevaluated and the expansion of current vaccination guidelines for groups that have elevated HA-related mortality rates should be considered.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Public Health Association